The ubiquitin proteasome system in neurodegenerative diseases: Sometimes the chicken, sometimes the egg

被引:773
作者
Ciechanover, A [1 ]
Brundin, P
机构
[1] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Dept Biochem, IL-31096 Haifa, Israel
[2] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Rappaport Family Inst Res Med Sci, IL-31096 Haifa, Israel
[3] Lund Univ, Dept Physiol Sci, Sect Neuronal Survival, Wallenberg Neurosci Ctr,Biomed Ctr, S-22184 Lund, Sweden
关键词
D O I
10.1016/S0896-6273(03)00606-8
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The ubiquitin-proteasome system targets numerous cellular proteins for degradation. In addition, modifications by ubiquitin-like proteins as well as proteins containing ubiquitin-interacting and -associated motifs modulate many others. This tightly controlled process involves multiple specific and general enzymes of the system as well as many modifying and ancillary proteins. Thus, it is not surprising that ubiquitin-mediated degradation/processing/modification regulates a broad array of basic cellular processes. Moreover, aberrations in the system have been implicated, either as a primary cause or secondary consequence, in the pathogenesis of both inherited and acquired neurodegenerative diseases. Recent findings indicate that the system is involved in the pathogenesis of Parkinson's, Alzheimer's, Huntington's, and Prion diseases as well as amyotrophic lateral sclerosis. This raises hopes for a better understanding of the pathogenetic mechanisms involved in these diseases and for the development of novel, mechanism-based therapeutic modalities.
引用
收藏
页码:427 / 446
页数:20
相关论文
共 165 条
  • [1] The proteasome: structure, function, and role in the cell
    Adams, J
    [J]. CANCER TREATMENT REVIEWS, 2003, 29 : 3 - 9
  • [2] True sporadic ALS associated with a novel SOD-1 mutation
    Alexander, MD
    Traynor, BJ
    Miller, N
    Corr, B
    Frost, E
    McQuaid, S
    Brett, FM
    Green, A
    Hardiman, O
    [J]. ANNALS OF NEUROLOGY, 2002, 52 (05) : 680 - 683
  • [3] Ubiquitin, cellular inclusions and their role in neurodegeneration
    Alves-Rodrigues, A
    Gregori, L
    Figueiredo-Pereira, ME
    [J]. TRENDS IN NEUROSCIENCES, 1998, 21 (12) : 516 - 520
  • [4] Proteasome activation and nNOS down-regulation in neuroblastoma cells expressing a Cu,Zn superoxide dismutase mutant involved in familial ALS
    Aquilano, K
    Rotilio, G
    Ciriolo, MR
    [J]. JOURNAL OF NEUROCHEMISTRY, 2003, 85 (05) : 1324 - 1335
  • [5] Dentatorubral and pallidoluysian atrophy (DRPLA) - Clinical and neuropathological findings in genetically confirmed North American and European pedigrees
    Becher, MW
    Rubinsztein, DC
    Leggo, J
    Wagster, MV
    Stine, OC
    Ranen, NG
    Franz, ML
    Abbott, MH
    Sherr, M
    MacMillan, JC
    Barron, L
    Porteous, M
    Harper, PS
    Ross, CA
    [J]. MOVEMENT DISORDERS, 1997, 12 (04) : 519 - 530
  • [6] The septin CDCrel-1 binds syntaxin and inhibits exocytosis
    Beites, CL
    Xie, H
    Bowser, R
    Trimble, WS
    [J]. NATURE NEUROSCIENCE, 1999, 2 (05) : 434 - 439
  • [7] Impairment of the ubiquitin-proteasome system by protein aggregation
    Bence, NF
    Sampat, RM
    Kopito, RR
    [J]. SCIENCE, 2001, 292 (5521) : 1552 - 1555
  • [8] Degradation of α-synuclein by proteasome
    Bennett, MC
    Bishop, JF
    Leng, Y
    Chock, PB
    Chase, TN
    Mouradian, MM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (48) : 33855 - 33858
  • [9] Bercovich B, 1997, J BIOL CHEM, V272, P9002
  • [10] Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism
    Bonifati, V
    Rizzu, P
    van Baren, MJ
    Schaap, O
    Breedveld, GJ
    Krieger, E
    Dekker, MCJ
    Squitieri, F
    Ibanez, P
    Joosse, M
    van Dongen, JW
    Vanacore, N
    van Swieten, JC
    Brice, A
    Meco, G
    van Duijn, CM
    Oostra, BA
    Heutink, P
    [J]. SCIENCE, 2003, 299 (5604) : 256 - 259